Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare disorder leading to a deficiency of complex I of the respiratory chain and is characterized by neurological dysfunction, hepatic failure and cardiomyopathy.
Features include always present findings: Decreased activity of mitochondrial complex I; and common findings: Encephalopathy, Generalized hypotonia, Thickened heart muscle (hypertrophic cardiomyopathy), and Congestive heart failure and others. 36 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Muscles | 8 | Low muscle tone (hypotonia), Generalized hypotonia, Muscle weakness |
ACAD9 encodes acyl-CoA dehydrogenase family member 9 (621 aa). Together with NDUFAF1 and ECSIT, forms part of the mitochondrial complex I (MCIA),which is required for the biogenesis of respiratory Complex I (CI) and is therefore crucial for the activation of the oxidative phosphorylation system. Highest expression in Skin Not Sun Exposed Suprapubic (77.7 TPM) and Skin Sun Exposed Lower leg (65.6 TPM).
Acyl-CoA dehydrogenase 9 deficiency is caused by mutations in the ACAD9 gene on chromosome 3.
ACAD9 is classified as a druggable target with score 0.0.
135 pathogenic variants reported in ACAD9 in ClinVar, including hotspot variants NP_054768.2:p.Arg266Trp (2-star review) and NP_054768.2:p.Arg518Cys (2-star review).
Variant |
|---|
Genetic testing for ACAD9 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 1 always present feature, 22 common features.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for acyl-CoA dehydrogenase 9 deficiency.
5 publications have been identified in PubMed for acyl-CoA dehydrogenase 9 deficiency. Research spans Basic Science / Preclinical (60%), Review / Meta-Analysis (20%), and Case Report / Case Series (20%).
Wang M (2026). [PMID: 41888097](https://pubmed.ncbi.nlm.nih.gov/41888097/). *Cell Death Dis*. [Basic Science / Preclinical]
Jian J (2026). [PMID: 41861636](https://pubmed.ncbi.nlm.nih.gov/41861636/). *Ecotoxicol Environ Saf*. [Basic Science / Preclinical]
Giguet-Valard AG (2025). [PMID: 40806260](https://pubmed.ncbi.nlm.nih.gov/40806260/). *International journal of molecular sciences*. [Case Report / Case Series]
Li J (2025). [PMID: 40618880](https://pubmed.ncbi.nlm.nih.gov/40618880/). *Cancer letters*. [Basic Science / Preclinical]
Häberle J (2024). [PMID: 38837457](https://pubmed.ncbi.nlm.nih.gov/38837457/). *Journal of inherited metabolic disease*. [Review / Meta-Analysis]
Data assembled from 8 of 12 sources · Last updated Sep 19, 2026, 2:56 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about acyl-CoA dehydrogenase 9 deficiency
Lab test results |
6 |
Decreased activity of mitochondrial complex I, Elevated circulating hepatic transaminase concentration, Increased circulating lactate concentration |
Heart and blood vessels | 5 | Stroke, Thickened heart muscle (hypertrophic cardiomyopathy), Congestive heart failure |
Digestive system | 5 | Hepatic failure, Elevated circulating hepatic transaminase concentration, Microvesicular hepatic steatosis |
Brain and nerves | 4 | Encephalopathy, Stroke, Cerebral edema |
Blood and immune system | 1 | Low platelet count (thrombocytopenia) |
Growth and development | 1 | Failure to thrive |
Significance
Review Stars |
|---|
Hotspot |
|---|
NP_054768.2:p.Arg266Trp | Pathogenic/Likely pathogenic | 2 stars | Yes |
NP_054768.2:p.Arg518Cys | Pathogenic/Likely pathogenic | 2 stars | Yes |
NP_054768.2:p.Arg414Cys | Pathogenic/Likely pathogenic | 2 stars | Yes |
NP_054768.2:p.Phe120fs | Pathogenic/Likely pathogenic | 2 stars | Yes |
NP_054768.2:p.Ala326Pro | Pathogenic/Likely pathogenic | 2 stars | Yes |